AAAAAA
Results:
1-14
|
Results: 14
Authors:
Snyder, RO
Citation: Ro. Snyder, AAV and RT-PCR: True or false?, MOL THER, 1(5), 2000, pp. 389-390
Authors:
Mandel, RJ
Hardy, S
Snyder, RO
Naldini, L
Leff, SE
Citation: Rj. Mandel et al., Intracerebral gene transfer using viral vectors, NEUROMETH, 36, 2000, pp. 103-130
Authors:
Eslami, MH
Gangadharan, SP
Sui, X
Rhynhart, KK
Snyder, RO
Conte, MS
Citation: Mh. Eslami et al., Gene delivery to in situ veins: Differential effects of adenovirus and adeno-associated viral vectors, J VASC SURG, 31(6), 2000, pp. 1149-1159
Authors:
Miao, CH
Nakai, H
Thompson, AR
Storm, TA
Chiu, W
Snyder, RO
Kay, MA
Citation: Ch. Miao et al., Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: Cell cycling does not influence hepatocyte transduction, J VIROLOGY, 74(8), 2000, pp. 3793-3803
Authors:
Moskalenko, M
Chen, LL
van Roey, M
Donahue, BA
Snyder, RO
McArthur, JG
Patel, SD
Citation: M. Moskalenko et al., Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: Implications for gene therapy and virus structure, J VIROLOGY, 74(4), 2000, pp. 1761-1766
Authors:
Snyder, RO
Citation: Ro. Snyder, Adeno-associated virus-mediated gene delivery, J GENE MED, 1(3), 1999, pp. 166-175
Authors:
Donahue, BA
McArthur, JG
Spratt, SK
Bohl, D
Lagarde, C
Sanchez, L
Kaspar, BA
Sloan, BA
Lee, YL
Danos, O
Snyder, RO
Citation: Ba. Donahue et al., Selective uptake and sustained expression of AAV vectors following subcutaneous delivery, J GENE MED, 1(1), 1999, pp. 31-42
Authors:
Snyder, RO
Miao, C
Meuse, L
Tubb, J
Donahue, BA
Lin, HF
Stafford, DW
Patel, S
Thompson, AR
Nichols, T
Read, MS
Bellinger, DA
Brinkhous, KM
Kay, MA
Citation: Ro. Snyder et al., Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors, NAT MED, 5(1), 1999, pp. 64-70
Authors:
Szczypka, MS
Mandel, RJ
Donahue, BA
Snyder, RO
Leff, SE
Palmiter, RD
Citation: Ms. Szczypka et al., Viral gene delivery selectively restores feeding and prevents lethality ofdopamine-deficient mice, NEURON, 22(1), 1999, pp. 167-178
Authors:
Leff, SE
Spratt, SK
Snyder, RO
Mandel, RJ
Citation: Se. Leff et al., Long-term restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's disease, NEUROSCIENC, 92(1), 1999, pp. 185-196
Authors:
Vincent-Lacaze, N
Snyder, RO
Gluzman, R
Bohl, D
Lagarde, C
Danos, O
Citation: N. Vincent-lacaze et al., Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle, J VIROLOGY, 73(3), 1999, pp. 1949-1955
Authors:
Mandel, RJ
Snyder, RO
Leff, SE
Citation: Rj. Mandel et al., Recombinant adeno-associated viral vector-mediated glial cell line-derivedneurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease, EXP NEUROL, 160(1), 1999, pp. 205-214
Authors:
Mandel, RJ
Rendahl, KG
Snyder, RO
Leff, SE
Citation: Rj. Mandel et al., Progress in direct striatal delivery of L-dopa via gene therapy for treatment of Parkinson's disease using recombinant adeno-associated viral vectors, EXP NEUROL, 159(1), 1999, pp. 47-64
Authors:
Mandel, RJ
Gage, FH
Clevenger, DG
Spratt, SK
Snyder, RO
Leff, SE
Citation: Rj. Mandel et al., Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration, EXP NEUROL, 155(1), 1999, pp. 59-64
Risultati:
1-14
|